Skip to main content

Day: October 25, 2019

Cleartronic, Inc. (CLRI) Acquires ReadyMed Software Platform

BOCA RATON, Fla., Oct. 25, 2019 (GLOBE NEWSWIRE) — Cleartronic, Inc. (CLRI: OTCPINK), announces acquiring the ReadyMed software platform from Collabria, LLC, a communications software company based in Tampa, Florida.ReadyMed, a web based secure communication platform for the health care industry, designed for hospitals, clinics, doctor’s offices, health insurance companies and many other segments of the health care sectors. It provides hospitals with patient tracking capability within the hospital. It allows physicians to track patient progress after release from the hospital, and allows for secure communication with the patient to follow the healing process, record their recovery and monitor their progress.The “Acquisition Agreement” provides for the acquisition of substantially all the assets and business operations of ReadyMed....

Continue reading

Farmers & Merchants Bancorp Reports Record Third Quarter and Year-to-Date 2019 Earnings

LODI, Calif., Oct. 25, 2019 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp (OTCQX: FMCB) today announced record third quarter and year-to-date net income.For the quarter ended September 30, 2019, Farmers & Merchants Bancorp reported net income of $13.7 million, or $17.45 per share, a 14.5% increase from net income of $12.0 million earned in the third quarter of 2018. Net interest income for the quarter ended September 30, 2019 was $35.3 million, up 10.6% from the same quarter in 2018. The Company’s net interest margin on a tax equivalent basis was 4.31% in the third quarter of 2019, compared to 4.34% in the third quarter of 2018. Return on average assets for the third quarter of 2019 was 1.58%, and return on average equity was 15.76%.Total assets at quarter-end were $3.6 billion, up 12.1% from the third quarter of 2018....

Continue reading

Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 29, 2019 at 9:30 AM

MIRAMAR, Fla., Oct. 25, 2019 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that it will hold an investor conference call on Tuesday October 29, 2019 at 9:30 am.Joseph Moscato, Generex President & Chief Executive Officer stated: “I look forward to this conference call and invite all of our valuable shareholders to attend.”Dial-in instructions for the investor conference call will be announced prior to the meeting date.About Generex Biotechnology Corp.Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and...

Continue reading

Western Pacific Trust Company: New Company Articles in Effect

VANCOUVER, British Columbia, Oct. 25, 2019 (GLOBE NEWSWIRE) — WESTERN PACIFIC TRUST COMPANY [TRADING SYMBOL “WP” – TSXV] (the “Company”) –At its Annual General and Special Meeting on May 29, 2019, the shareholders of the Company passed the following Special Resolution:Consent to alter the Articles of the Company was received from FICOM on September 18, 2019, and the New Articles were accepted for filing by the TSX Venture Exchange on October 24, 2019.Accordingly the New Articles were deposited for filing at the Company’s records office at 920 – 789 West Pender Street, Vancouver, BC V6C 1H2 on October 24, 2019, and are now in full force and effect.The Company Articles can be viewed under the Company’s profile on SEDAR at www.sedar.com.About Western Pacific Trust CompanyWestern Pacific Trust Company is a non-deposit taking...

Continue reading

Guard Dog Provides Shareholder Update

BOULDER CITY, Nev., Oct. 25, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE – George Sharp, President of Guard Dog, Inc. (PINKSHEETS: GRDO) announced today that the company’s securities counsel is continuing to work with Nevada’s office of the Secretary of State to unwind and correct past corporate actions, which if left as is would have made it impossible for the corporation to move forward with its plans.  As a result of these past corporate actions, some going back as far as when the corporation was formed, the more recent actions initiated by current management also had to be unwound.  Shareholders may notice a series of temporary changes to the number of authorized and outstanding shares, but once the required and proper corporate actions have been completed, these numbers will return to their expected state and the company will resume...

Continue reading

FAX Capital Corp. Provides Update Regarding Share Consolidation and Offering

NOT FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO U.S. NEWS WIRE SERVICESTORONTO, Oct. 25, 2019 (GLOBE NEWSWIRE) — FAX Capital Corp. (the Company) (CSE: FXC) is issuing this press release to confirm and provide further details regarding the intended timing for the Share Consolidation and Offering, each as previously disclosed in the Company’s final prospectus dated October 18, 2019 (the Prospectus) and the press release issued that same date.Pursuant to the Offering, the Company proposes to issue to the public up to 33,333,333 units of the Company (Units) at a price of $4.50. Each Unit consists of one post-consolidation Subordinate Voting Share of the Company and a Subordinate Voting Share purchase warrant (the Founder Warrants). Each Founder Warrant will entitle the holder to acquire one post-consolidation Subordinate...

Continue reading

Zynerba Pharmaceuticals to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

DEVON, Pa., Oct. 25, 2019 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Zynerba’s Vice President of Communications and Investor Relations, Will Roberts, will present a company overview at the Dawson James Securities 5th Annual Small Cap Growth Conference. The presentation will take place on Tuesday, October 29th at 9:40AM EDT at the Wyndham Grand Jupiter. A live webcast of the presentation will be accessible on the Investor Relations page of http://www.zynerba.com.  About Zynerba Pharmaceuticals, Inc.Zynerba Pharmaceuticals is the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. We are...

Continue reading

Allied Corp., a Medical Cannabis Company, Announces Sponsorship of Next PTSD Healing Retreat in British Columbia

KELOWNA, British Columbia, Oct. 25, 2019 (GLOBE NEWSWIRE) — Allied Corp. (“Allied”) (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions, is pleased to announce the sponsorship of the next Allied Charitable Foundation (ACF) post-traumatic stress disorder (“PTSD”) healing retreat that is taking place October 25-28th, 2019 in British Columbia, Canada.  This retreat is using a similar format as the last Spring’s retreat given the previous overall success. The lead up to the retreat involves participants connecting with the retreat team, peer support and medical support if necessary. The retreat then involves an orientation to the physiology of PTSD, education, self-reflection, guided drumming, pneumosomatic breathing exercises, group activities...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.